- Aditum Bio, established by industry veterans Joe Jimenez and Mark Fishman, to fund clinical development
- Sosei Heptares to receive an upfront payment and strategic equity stake in Tempero Bio, plus future success-based milestone payments and tiered royalties
PR Newswire
TOKYO and CAMBRIDGE, England, Nov. 2, 2020